This is a StreetInsider.com Premium Only Page

(LVTX) – Analyst Comments

Mar 20, 2024 02:54 PM Jefferies Reiterates Buy Rating on Lava Therapeutics NV (LVTX) Following Earnings, 'LAVA 1266 tracking to 2Q24 IND submission'

Oct 25, 2022 06:30 AM UPDATE: H.C. Wainwright Starts Lava Therapeutics NV (LVTX) at Buy

Sep 28, 2022 06:04 AM

Sep 15, 2022 04:30 AM

Apr 19, 2021 08:02 AM

Apr 19, 2021 05:37 AM